Robert T. Dess

4.7k total citations · 1 hit paper
102 papers, 1.6k citations indexed

About

Robert T. Dess is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Robert T. Dess has authored 102 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 33 papers in Radiation and 15 papers in Surgery. Recurrent topics in Robert T. Dess's work include Prostate Cancer Diagnosis and Treatment (69 papers), Prostate Cancer Treatment and Research (68 papers) and Advanced Radiotherapy Techniques (33 papers). Robert T. Dess is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (69 papers), Prostate Cancer Treatment and Research (68 papers) and Advanced Radiotherapy Techniques (33 papers). Robert T. Dess collaborates with scholars based in United States, Canada and Egypt. Robert T. Dess's co-authors include Daniel E. Spratt, Matthew J. Schipper, Will Jackson, Payal Soni, Felix Y. Feng, James A. Hayman, Yilun Sun, Shruti Jolly, Theodore S. Lawrence and M.M. Matuszak and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Robert T. Dess

84 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non–Small-Cell Lung Cancer

2017 259 citations Robert T. Dess, Yilun Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert T. Dess United States	20	1.0k	412	361	358	216	102	1.6k
David Pryor Australia	20	757 0.7×	352 0.9×	271 0.8×	382 1.1×	385 1.8×	85	1.4k
Eric M. Horwitz United States	21	950 0.9×	293 0.7×	661 1.8×	311 0.9×	179 0.8×	41	1.6k
Ronald D. Ennis United States	24	1.2k 1.2×	280 0.7×	454 1.3×	528 1.5×	525 2.4×	102	2.0k
Paul Martin Putora Switzerland	22	907 0.9×	445 1.1×	153 0.4×	303 0.8×	237 1.1×	110	1.6k
Alberto Bossi France	28	1.8k 1.8×	487 1.2×	527 1.5×	561 1.6×	556 2.6×	106	2.6k
Brent S. Rose United States	28	1.2k 1.2×	807 2.0×	412 1.1×	424 1.2×	766 3.5×	171	2.6k
Christopher Morash Canada	30	1.6k 1.6×	211 0.5×	231 0.6×	346 1.0×	776 3.6×	143	2.4k
P. Kil Netherlands	16	954 0.9×	252 0.6×	181 0.5×	106 0.3×	348 1.6×	36	1.3k
Alan Herschtal Australia	25	930 0.9×	732 1.8×	477 1.3×	643 1.8×	317 1.5×	80	2.0k
Peter Kirkbride Canada	18	621 0.6×	530 1.3×	209 0.6×	150 0.4×	793 3.7×	33	1.8k

Countries citing papers authored by Robert T. Dess

Since Specialization

Citations

This map shows the geographic impact of Robert T. Dess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Dess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Dess more than expected).

Fields of papers citing papers by Robert T. Dess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Dess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Dess. The network helps show where Robert T. Dess may publish in the future.

Co-authorship network of co-authors of Robert T. Dess

This figure shows the co-authorship network connecting the top 25 collaborators of Robert T. Dess. A scholar is included among the top collaborators of Robert T. Dess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert T. Dess. Robert T. Dess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gonzalez, Richard, Will Jackson, Megan E.V. Caram, et al.. (2025). Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System. Journal of Nuclear Medicine. 66(1). 75–83. 5 indexed citations

2.

Lukka, Himu, Stephanie L. Pugh, William U. Shipley, et al.. (2025). Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy. International Journal of Radiation Oncology*Biology*Physics. 123(4). 990–999. 1 indexed citations

3.

Dykstra, Michael, Huiying Yin, Mark Zaki, et al.. (2024). Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality Consortium. Advances in Radiation Oncology. 9(11). 101629–101629. 1 indexed citations

4.

Hoffman, Richard M., Paul L. Nguyen, Dana E. Rathkopf, et al.. (2024). Long-Term Patient-Reported Health-Related Quality of Life in the Randomized FORMULA-509 Trial of Salvage Radiotherapy and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate Plus Prednisone and Apalutamide after Radical Prostatectomy. International Journal of Radiation Oncology*Biology*Physics. 120(2). S54–S54.

5.

Michalski, Jeff M., Jennifer Moughan, James A. Purdy, et al.. (2023). Long-Term Outcomes of NRG/RTOG 0126, a Randomized Trial of High Dose (79.2 Gy) vs. Standard Dose (70.2 Gy) Radiation Therapy (RT) for Men with Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). S4–S5. 3 indexed citations

6.

Nguyen, Paul L., Marisa Kollmeier, Dana E. Rathkopf, et al.. (2023). FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP). International Journal of Radiation Oncology*Biology*Physics. 117(2). S81–S82. 1 indexed citations

7.

Vince, Randy, Merrick Bank, Yilun Sun, et al.. (2023). Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients. JAMA Network Open. 6(1). e2250416–e2250416. 46 indexed citations

8.

Chase, Elizabeth C., Alex K. Bryant, Yilun Sun, et al.. (2022). Development and validation of a life expectancy calculator for US patients with prostate cancer. British Journal of Urology. 130(4). 496–506. 3 indexed citations

9.

Alshalalfa, Mohammed, Idalid Franco, Randy Vince, et al.. (2022). Clinicogenomic characterization of prostate cancer liver metastases. Prostate Cancer and Prostatic Diseases. 25(2). 366–369. 13 indexed citations

10.

Vince, Randy, Ji Qi, Jeffrey J. Tosoian, et al.. (2021). Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative. Prostate Cancer and Prostatic Diseases. 25(4). 677–683. 19 indexed citations

11.

Zaorsky, Nicholas G., James B. Yu, Sean M. McBride, et al.. (2020). Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances in Radiation Oncology. 5(4). 659–665. 124 indexed citations

12.

Zaorsky, Nicholas G., James B. Yu, Sean M. McBride, et al.. (2020). Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances in Radiation Oncology. 5. 26–32. 17 indexed citations

13.

Dee, Edward Christopher, Vinayak Muralidhar, Amar U. Kishan, et al.. (2020). Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 109(5). 1279–1285. 17 indexed citations

14.

Butler, Santino, Idalid Franco, Vinayak Muralidhar, et al.. (2019). Conservative management of low‐risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database. Cancer. 125(19). 3338–3346. 13 indexed citations

15.

Dess, Robert T., Yilun Sun, Daniel G. Muenz, et al.. (2019). Cardiac Dose in Locally Advanced Lung Cancer: Results From a Statewide Consortium. Practical Radiation Oncology. 10(1). e27–e36. 13 indexed citations

16.

Dess, Robert T., Payal Soni, Will Jackson, et al.. (2019). The current state of randomized clinical trial evidence for prostate brachytherapy. Urologic Oncology Seminars and Original Investigations. 37(9). 599–610. 7 indexed citations

17.

Hawkins, Peter G., Yilun Sun, Robert T. Dess, et al.. (2019). Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 145(6). 1635–1643. 37 indexed citations

18.

Dess, Robert T., Todd M. Morgan, Paul L. Nguyen, et al.. (2017). Adjuvant Versus Early Salvage Radiation Therapy Following Radical Prostatectomy for Men with Localized Prostate Cancer. Current Urology Reports. 18(7). 55–55. 8 indexed citations

19.

Spratt, Daniel E., Robert T. Dess, Zachary S. Zumsteg, et al.. (2017). A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. European Urology. 73(2). 156–165. 40 indexed citations

20.

Spratt, Daniel E., Robert T. Dess, & Felix Y. Feng. (2017). Reply to Pirus Ghadjar and Thomas Wiegel's Letter to the Editor re: Daniel E. Spratt, Robert T. Dess, Zachary S. Zumsteg, et al. A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer. Eur Urol 2018;73:156–65. European Urology. 73(3). e64–e65.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact